<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract At the time of diagnosis, 20% to 25% of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> already have <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, the presence of which is a most important prognostic factor </plain></SENT>
<SENT sid="1" pm="."><plain>A 64-year-old man was admitted to our hospital for investigation of <z:hpo ids='HP_0001903'>anemia</z:hpo> and multiple <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Examinations revealed ascending colon <z:mp ids='MP_0002038'>carcinoma</z:mp> with more than 40 liver <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and 2 lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We performed right hemicolectomy with lymph node dissection, which was followed by <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi>/leucovorin, <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, plus bevacizumab (FOLFOX-BV) </plain></SENT>
<SENT sid="4" pm="."><plain>After 4 courses of chemotherapy, the <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">lung metastases</z:e> were in complete remission and the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> had shrunk </plain></SENT>
<SENT sid="5" pm="."><plain>We suggested the option of radical liver resection, but the patient declined initially as he had not suffered any severe side effects of FOLFOX-BV </plain></SENT>
<SENT sid="6" pm="."><plain>After 23 courses of the chemotherapy, he agreed to undergo hepatectomy </plain></SENT>
<SENT sid="7" pm="."><plain>We performed extended right lobectomy with partial left and caudal lobe resection </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the macroscopic metastatic lesions were resected </plain></SENT>
<SENT sid="9" pm="."><plain>Histopathologically, viable <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells were recognized in 7 of the 43 liver metastatic lesions </plain></SENT>
<SENT sid="10" pm="."><plain>Postoperatively, FOLFOX-BV was restarted and continued for 10 months </plain></SENT>
<SENT sid="11" pm="."><plain>At the time of writing, 15 months after the hepatectomy, the patient was well without evidence of recurrence of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>